当前位置: X-MOL 学术J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Small-Molecule Lead-Finding Trends across the Roche and Genentech Research Organizations
Journal of Medicinal Chemistry ( IF 6.8 ) Pub Date : 2022-02-09 , DOI: 10.1021/acs.jmedchem.1c02106
Peter S Dragovich 1 , Wolfgang Haap 2 , Melinda M Mulvihill 1 , Jean-Marc Plancher 2 , Antonia F Stepan 2
Affiliation  

The origin of small-molecule leads that were pursued across the independent research organizations Roche and Genentech from 2009 to 2020 is described. The identified chemical series are derived from a variety of lead-finding methods, which include public information, high-throughput screening (both full file and focused), fragment-based design, DNA-encoded library technology, use of legacy internal data, in-licensing, and de novo design (often structure-based). The translation of the lead series into in vivo tool compounds and development candidates is discussed as are the associated biological target classes and corresponding therapeutic areas. These analyses identify important trends regarding the various lead-finding approaches, which will likely impact their future application in the Roche and Genentech research groups. They also highlight commonalities and differences across the two independent research organizations. Several caveats associated with the employed data collection and analysis methodologies are included to enhance the interpretation of the presented information.

中文翻译:

罗氏和基因泰克研究机构的小分子先导发现趋势

描述了 2009 年至 2020 年独立研究机构罗氏和基因泰克所追求的小分子先导的起源。已识别的化学系列来源于多种先导发现方法,包括公共信息、高通量筛选(全文件和重点筛选)、基于片段的设计、DNA 编码库技术、使用遗留内部数据、 - 许可和从头设计(通常基于结构)。讨论了将先导系列转化为体内工具化合物和开发候选物,以及相关的生物靶标类别和相应的治疗领域。这些分析确定了有关各种先导发现方法的重要趋势,这可能会影响它们在罗氏和基因泰克研究小组中的未来应用。他们还强调了两个独立研究机构的共同点和不同点。包括与所采用的数据收集和分析方法相关的几个警告,以增强对所提供信息的解释。
更新日期:2022-02-09
down
wechat
bug